Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Cash from Operations (2016 - 2025)

Amicus Therapeutics filings provide 16 years of Cash from Operations readings, the most recent being 16253000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 515.04% to 16253000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 33145000.0, a 197.8% increase, with the full-year FY2025 number at 33145000.0, up 197.8% from a year prior.
  • Cash from Operations hit 16253000.0 in Q4 2025 for Amicus Therapeutics, down from 35660000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 35660000.0 in Q3 2025 to a low of 80772000.0 in Q4 2022.
  • Median Cash from Operations over the past 5 years was 20520000.0 (2023), compared with a mean of 21945150.0.
  • Biggest five-year swings in Cash from Operations: crashed 229.84% in 2023 and later soared 515.04% in 2025.
  • Amicus Therapeutics' Cash from Operations stood at 70514000.0 in 2021, then dropped by 14.55% to 80772000.0 in 2022, then surged by 104.28% to 3458000.0 in 2023, then crashed by 213.24% to 3916000.0 in 2024, then soared by 515.04% to 16253000.0 in 2025.
  • The last three reported values for Cash from Operations were 16253000.0 (Q4 2025), 35660000.0 (Q3 2025), and 26526000.0 (Q2 2025) per Business Quant data.